7UDH
| Integrin alpha IIB beta3 complex with BMS4-3 | 分子名称: | (4-{[(5S)-3-(piperidin-4-yl)-4,5-dihydro-1,2-oxazol-5-yl]methyl}piperazin-1-yl)acetic acid, 10E5 Fab heavy chain, 10E5 Fab light chain, ... | 著者 | Lin, F.-Y, Zhu, J, Zhu, J, Springer, T.A. | 登録日 | 2022-03-19 | 公開日 | 2022-08-17 | 最終更新日 | 2024-10-16 | 実験手法 | X-RAY DIFFRACTION (1.99998844 Å) | 主引用文献 | A general chemical principle for creating closure-stabilizing integrin inhibitors. Cell, 185, 2022
|
|
7UK9
| Integrin alpha IIB beta3 complex with lamifiban (Mn) | 分子名称: | 10E5 Fab heavy chain, 10E5 Fab light chain, 2-acetamido-2-deoxy-beta-D-glucopyranose, ... | 著者 | Lin, F.-Y, Zhu, J, Zhu, J, Springer, T.A. | 登録日 | 2022-03-31 | 公開日 | 2022-08-17 | 最終更新日 | 2024-10-23 | 実験手法 | X-RAY DIFFRACTION (2.60001969 Å) | 主引用文献 | A general chemical principle for creating closure-stabilizing integrin inhibitors. Cell, 185, 2022
|
|
7UFH
| Integrin alpha IIB beta3 complex with fradafiban (Mn/Ca) | 分子名称: | 10E5 Fab heavy chain, 10E5 Fab light chain, 2-acetamido-2-deoxy-beta-D-glucopyranose, ... | 著者 | Lin, F.-Y, Zhu, J, Zhu, J, Springer, T.A. | 登録日 | 2022-03-22 | 公開日 | 2022-08-17 | 最終更新日 | 2024-10-02 | 実験手法 | X-RAY DIFFRACTION (2.99768162 Å) | 主引用文献 | A general chemical principle for creating closure-stabilizing integrin inhibitors. Cell, 185, 2022
|
|
7UKT
| Integrin alpha IIB beta3 complex with BMS4.2 | 分子名称: | (1-{[(5S)-3-(4-carbamimidoylphenyl)-4,5-dihydro-1,2-oxazol-5-yl]methyl}piperidin-4-yl)acetic acid, 10E5 Fab heavy chain, 10E5 Fab light chain, ... | 著者 | Lin, F.-Y, Zhu, J, Zhu, J, Springer, T.A. | 登録日 | 2022-04-01 | 公開日 | 2022-08-17 | 最終更新日 | 2024-10-30 | 実験手法 | X-RAY DIFFRACTION (2.36994433 Å) | 主引用文献 | A general chemical principle for creating closure-stabilizing integrin inhibitors. Cell, 185, 2022
|
|
7U9V
| Integrin alpha IIB beta3 complex with BMS4-1 | 分子名称: | (4-{[(5S)-3-(4-carbamimidoylphenyl)-4,5-dihydro-1,2-oxazol-5-yl]methyl}piperazin-1-yl)acetic acid, 10E5 Fab heavy chain, 10E5 light chain, ... | 著者 | Zhu, J, Lin, F.-Y, Zhu, J, Springer, T.A. | 登録日 | 2022-03-11 | 公開日 | 2022-08-17 | 最終更新日 | 2024-11-06 | 実験手法 | X-RAY DIFFRACTION (2.25492167 Å) | 主引用文献 | A general chemical principle for creating closure-stabilizing integrin inhibitors. Cell, 185, 2022
|
|
7UCY
| Integrin alpha IIB beta3 complex with gantofiban | 分子名称: | (4-{[(5R)-3-(4-carbamimidoylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl}piperazin-1-yl)acetic acid, 10E5 Fab heavy chain, 10E5 Fab light chain, ... | 著者 | Lin, F.-Y, Zhu, J, Zhu, J, Springer, T.A. | 登録日 | 2022-03-17 | 公開日 | 2022-08-17 | 最終更新日 | 2024-10-02 | 実験手法 | X-RAY DIFFRACTION (2.34996319 Å) | 主引用文献 | A general chemical principle for creating closure-stabilizing integrin inhibitors. Cell, 185, 2022
|
|
7UKO
| Integrin alpha IIB beta3 complex with sibrafiban (Mn) | 分子名称: | 10E5 Fab heavy chain, 10E5 Fab light chain, 2-acetamido-2-deoxy-beta-D-glucopyranose, ... | 著者 | Lin, F.-Y, Zhu, J, Zhu, J, Springer, T.A. | 登録日 | 2022-04-01 | 公開日 | 2022-08-17 | 最終更新日 | 2024-10-16 | 実験手法 | X-RAY DIFFRACTION (2.604 Å) | 主引用文献 | A general chemical principle for creating closure-stabilizing integrin inhibitors. Cell, 185, 2022
|
|
7UJK
| Integrin alpha IIB beta3 complex with lamifiban | 分子名称: | 10E5 Fab heavy chain, 10E5 Fab light chain, 2-acetamido-2-deoxy-beta-D-glucopyranose, ... | 著者 | Lin, F.-Y, Zhu, J, Zhu, J, Springer, T.A. | 登録日 | 2022-03-30 | 公開日 | 2022-08-17 | 最終更新日 | 2024-10-02 | 実験手法 | X-RAY DIFFRACTION (2.43265581 Å) | 主引用文献 | A general chemical principle for creating closure-stabilizing integrin inhibitors. Cell, 185, 2022
|
|
7UDG
| Integrin alpha IIB beta3 complex with lotrafiban | 分子名称: | 10E5 Fab heavy chain, 10E5 Fab light chain, 2-acetamido-2-deoxy-beta-D-glucopyranose, ... | 著者 | Lin, F.-Y, Zhu, J, Zhu, J, Springer, T.A. | 登録日 | 2022-03-19 | 公開日 | 2022-08-17 | 最終更新日 | 2024-11-06 | 実験手法 | X-RAY DIFFRACTION (2.800069 Å) | 主引用文献 | A general chemical principle for creating closure-stabilizing integrin inhibitors. Cell, 185, 2022
|
|
7U9F
| Integrin alpha IIB beta3 complex with BMS compound 4 in Mn2+ | 分子名称: | (4-{[(5S)-3-{4-[(E)-imino(4-methylpiperazin-1-yl)methyl]phenyl}-4,5-dihydro-1,2-oxazol-5-yl]methyl}piperazin-1-yl)acetic acid, 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ... | 著者 | Lin, F.-Y, Zhu, J, Zhu, J, Springer, T.A. | 登録日 | 2022-03-10 | 公開日 | 2022-08-17 | 最終更新日 | 2024-10-30 | 実験手法 | X-RAY DIFFRACTION (2.70000529 Å) | 主引用文献 | A general chemical principle for creating closure-stabilizing integrin inhibitors. Cell, 185, 2022
|
|
7UE0
| Integrin alpha IIB beta3 complex with fradafiban | 分子名称: | 10E5 Fab heavy chain, 10E5 Fab light chain, 2-acetamido-2-deoxy-beta-D-glucopyranose, ... | 著者 | Lin, F.-Y, Zhu, J, Zhu, J, Springer, T.A. | 登録日 | 2022-03-20 | 公開日 | 2022-08-17 | 最終更新日 | 2024-10-02 | 実験手法 | X-RAY DIFFRACTION (2.741962 Å) | 主引用文献 | A general chemical principle for creating closure-stabilizing integrin inhibitors. Cell, 185, 2022
|
|
7UKP
| Integrin alpha IIB beta3 complex with a gantofiban analog | 分子名称: | 10E5 Fab heavy chain, 10E5 Fab light chain, 2-acetamido-2-deoxy-beta-D-glucopyranose, ... | 著者 | Lin, F.-Y, Zhu, J, Zhu, J, Springer, T.A. | 登録日 | 2022-04-01 | 公開日 | 2022-08-17 | 最終更新日 | 2024-11-06 | 実験手法 | X-RAY DIFFRACTION (2.80112982 Å) | 主引用文献 | A general chemical principle for creating closure-stabilizing integrin inhibitors. Cell, 185, 2022
|
|
7UBR
| Integrin alpha IIB beta3 complex with GR144053 | 分子名称: | 10E5 Fab heavy chain, 10E5 Fab light chain, 2-acetamido-2-deoxy-beta-D-glucopyranose, ... | 著者 | Lin, F.-Y, Zhu, J, Zhu, J, Springer, T.A. | 登録日 | 2022-03-15 | 公開日 | 2022-08-17 | 最終更新日 | 2024-10-16 | 実験手法 | X-RAY DIFFRACTION (2.04992747 Å) | 主引用文献 | A general chemical principle for creating closure-stabilizing integrin inhibitors. Cell, 185, 2022
|
|
7UJE
| Integrin alpha IIB beta3 complex with UR2922 in Mn2+ | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, CALCIUM ION, ... | 著者 | Lin, F.-Y, Zhu, J, Zhu, J, Springer, T.A. | 登録日 | 2022-03-30 | 公開日 | 2022-08-17 | 最終更新日 | 2024-10-02 | 実験手法 | X-RAY DIFFRACTION (2.499968 Å) | 主引用文献 | A general chemical principle for creating closure-stabilizing integrin inhibitors. Cell, 185, 2022
|
|
7UH8
| Integrin alpha IIB beta3 complex with roxifiban (Mn/Ca) | 分子名称: | 10E5 Fab heavy chain, 10E5 Fab light chain, 2-acetamido-2-deoxy-beta-D-glucopyranose, ... | 著者 | Lin, F.-Y, Zhu, J, Zhu, J, Springer, T.A. | 登録日 | 2022-03-25 | 公開日 | 2022-08-17 | 最終更新日 | 2024-10-02 | 実験手法 | X-RAY DIFFRACTION (2.750024 Å) | 主引用文献 | A general chemical principle for creating closure-stabilizing integrin inhibitors. Cell, 185, 2022
|
|
8IKL
| Cryo-EM structure of the CD97-G13 complex | 分子名称: | Adhesion G protein-coupled receptor E5, Guanine nucleotide-binding protein G(13) subunit alpha isoforms short, Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2, ... | 著者 | Mao, C, Zhao, R, Dong, Y, Gao, M, Chen, L, Zhang, C, Xiao, P. | 登録日 | 2023-02-28 | 公開日 | 2024-01-24 | 最終更新日 | 2024-02-14 | 実験手法 | ELECTRON MICROSCOPY (2.33 Å) | 主引用文献 | Conformational transitions and activation of the adhesion receptor CD97. Mol.Cell, 84, 2024
|
|
5UHB
| Crystal structure of Mycobacterium tuberculosis transcription initiation complex in complex with Rifampin | 分子名称: | DNA (5'-D(*CP*AP*TP*CP*CP*GP*TP*GP*AP*GP*TP*CP*GP*AP*GP*G)-3'), DNA (5'-D(*TP*AP*TP*AP*AP*TP*GP*GP*GP*AP*GP*CP*TP*GP*TP*CP*AP*CP*GP*GP*AP*TP*G)-3'), DNA-directed RNA polymerase subunit alpha, ... | 著者 | Lin, W, Das, K, Feng, Y, Ebright, R.H. | 登録日 | 2017-01-11 | 公開日 | 2017-04-12 | 最終更新日 | 2017-11-22 | 実験手法 | X-RAY DIFFRACTION (4.29 Å) | 主引用文献 | Structural Basis of Mycobacterium tuberculosis Transcription and Transcription Inhibition. Mol. Cell, 66, 2017
|
|
7MLJ
| |
6W5N
| Cryo-EM structure of MLL1 in complex with RbBP5, WDR5, SET1, and ASH2L bound to the nucleosome (Class05) | 分子名称: | DNA (147-MER), Histone H2A type 1, Histone H2B 1.1, ... | 著者 | Park, S.H, Lee, Y.T, Ayoub, A, Dou, Y, Cho, U. | 登録日 | 2020-03-13 | 公開日 | 2021-03-31 | 最終更新日 | 2024-05-29 | 実験手法 | ELECTRON MICROSCOPY (6 Å) | 主引用文献 | Mechanism for DPY30 and ASH2L intrinsically disordered regions to modulate the MLL/SET1 activity on chromatin. Nat Commun, 12, 2021
|
|
6W5I
| Cryo-EM structure of MLL1 in complex with RbBP5, WDR5, SET1, and ASH2L bound to the nucleosome (Class01) | 分子名称: | DNA (147-MER), Histone H2A, Histone H2B 1.1, ... | 著者 | Park, S.H, Lee, Y.T, Ayoub, A, Dou, Y, Cho, U. | 登録日 | 2020-03-13 | 公開日 | 2021-03-31 | 最終更新日 | 2024-05-29 | 実験手法 | ELECTRON MICROSCOPY (6.9 Å) | 主引用文献 | Mechanism for DPY30 and ASH2L intrinsically disordered regions to modulate the MLL/SET1 activity on chromatin. Nat Commun, 12, 2021
|
|
6W5M
| Cryo-EM structure of MLL1 in complex with RbBP5, WDR5, SET1, and ASH2L bound to the nucleosome (Class02) | 分子名称: | DNA (147-MER), Histone H2A type 1, Histone H2B 1.1, ... | 著者 | Park, S.H, Lee, Y.T, Ayoub, A, Dou, Y, Cho, U. | 登録日 | 2020-03-13 | 公開日 | 2021-03-31 | 最終更新日 | 2024-05-29 | 実験手法 | ELECTRON MICROSCOPY (4.6 Å) | 主引用文献 | Mechanism for DPY30 and ASH2L intrinsically disordered regions to modulate the MLL/SET1 activity on chromatin. Nat Commun, 12, 2021
|
|
7E7Y
| |
7E88
| |
7E86
| |
7W33
| The crystal structure of human CtsL in complex with 14a | 分子名称: | N-[(2S)-3-(4-fluorophenyl)-1-oxidanylidene-1-[[(2R,3S)-3-oxidanyl-4-oxidanylidene-1-[(3S)-2-oxidanylidenepiperidin-3-yl]-4-[(phenylmethyl)amino]butan-2-yl]amino]propan-2-yl]-1-benzofuran-2-carboxamide, Procathepsin L | 著者 | Zhao, Y, Shao, M, Zhao, J, Yang, H, Rao, Z. | 登録日 | 2021-11-25 | 公開日 | 2023-05-31 | 最終更新日 | 2024-10-23 | 実験手法 | X-RAY DIFFRACTION (2.39 Å) | 主引用文献 | Structure-based design of pan-coronavirus inhibitors targeting host cathepsin L and calpain-1. Signal Transduct Target Ther, 9, 2024
|
|